CrystalGenomics (083790 KS): Partner’s Clinical Data Presentation Is Not a Buying Opportunity
Partner's clinical trial data presentation at an upcoming conference does not represent upside potential for CrystalGenomics shares.
194 Views
HK Inno.N (INNO KS): On a Solid Growth Path with Blockbuster New Drug K-CAB
K-CAB has already become the no. 1 drug in Korean digestive treatment market. Thus far, K-CAB has marketing partnerships with 24 countries.
421 Views
KRX BBIG Index Rebalance: Krafton, SK Bioscience, SK IE Tech Included (Among Others)
Krafton has been added to the Game index, SK IE Tech added to the Battery index, SK Bioscience to the Bio index. Lots of flow on some names....
238 Views
KRX BBIG Index Rebalance Preview: Worth a Look
There are lots of changes expected to the KRX BBIG indices at the September review. With a large amount of assets tracking the indices, some of the...
469 Views
Closing the Gap: Korean Holdcos Vs. Opcos
In this insight, we highlight the closing of the pricing gaps between the major Korean holdcos and opcos, especially with the upcoming end of the...
367 Views